Publications by authors named "R Travers"

Claim this Profile
P
Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.
Alec Stepanian, Richard J Travers, Angelina Tesfu, Nicole L Wolter, Joshua J Man

Circulation· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Permissive Cardiotoxicity and Determination of Anthracycline Risk With Previous Anthracycline Exposure.
Richard J Travers, Nicholas Camarda, Iris Z Jaffe, Raphael A Lizcano, Jenica N Upshaw

JACC Case Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelium as a Source of Cardiovascular Toxicity From Antitumor Kinase Inhibitors.
Richard J Travers, Alec Stepanian, Iris Z Jaffe

Arterioscler Thromb Vasc Biol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying mitigating strategies for endothelial cell dysfunction and hypertension in response to VEGF receptor inhibitors.
Nicholas D Camarda, Qing Lu, Dawn M Meola, Joshua J Man, Zeyuan Song, Richard J Travers

Clin Sci (Lond)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antipolyphosphate monoclonal antibodies derived from autoimmune mice.
Josepha C Sedzro, Stephanie A Smith, Alexander Scott, Yuqi Wang, Richard J Travers

Res Pract Thromb Haemost· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis